Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1983 Nov;80(3):519–525. doi: 10.1111/j.1476-5381.1983.tb10724.x

The inhibitory effects of N2-dansyl-L-arginine-4-t-butylpiperidine amide (TI233) on contraction of vascular and intestinal smooth muscle.

H Karaki, K Murakami, H Nakagawa, N Urakawa
PMCID: PMC2045006  PMID: 6640205

Abstract

Effects of N2-dansyl-L-arginine-4-t-butylpiperidine amide (TI233) on the contractions in vascular and intestinal smooth muscles were examined. High K-induced sustained contractions in the smooth muscles were inhibited by TI233 with an IC50 of 2.1 X 10(-5) M for rabbit aorta and 3.6 X 10(-6) M for guinea-pig taenia coli in a solution containing 1.5 mM Ca. Initial transient contraction induced by K in taenia coli was less sensitive to the inhibitory effect of TI233. When the Ca concentration in the medium was decreased to 0.3 mM, the concentration-inhibition curves for TI233 shifted to the left in both aorta and taenia coli. Increasing the Ca concentration to 7.5 mM shifted the curve to the right in the aorta. TI233 also inhibited the noradrenaline-induced contraction in the aorta (IC50 = 2.1 X 10(-5 M). In a hypoxic solution without added glucose, the inhibitory effect of TI233 on the K-induced contraction in aorta was augmented. In the presence of high concentrations (40 mM) of glucose in hypoxia, TI233 did not inhibit the noradrenaline-induced contraction of the aorta. Hypoxia and a high concentration of glucose also decreased the inhibitory effect of TI233 on the K-induced contraction in taenia coli. TI233 inhibited the K-induced increase in cellular Ca content measured by a modified lanthanum method. TI233 decreased oxygen consumption and ATP content of resting and K-stimulated aorta and taenia coli. It was concluded that TI233 inhibits the vascular and intestinal smooth muscle contraction by a Ca antagonistic action and also by inhibition of aerobic metabolism.

Full text

PDF
519

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Coe J., Detar R., Bohr D. F. Substrates and vascular smooth muscle contraction. Am J Physiol. 1968 Feb;214(2):245–250. doi: 10.1152/ajplegacy.1968.214.2.245. [DOI] [PubMed] [Google Scholar]
  2. Detar R., Bohr D. F. Oxygen and vascular smooth muscle contraction. Am J Physiol. 1968 Feb;214(2):241–244. doi: 10.1152/ajplegacy.1968.214.2.241. [DOI] [PubMed] [Google Scholar]
  3. FURCHGOTT R. F. Spiral-cut strip of rabbit aorta for in vitro studies of responses of arterial smooth muscle. Methods Med Res. 1960;8:177–186. [PubMed] [Google Scholar]
  4. Hidaka H., Yamaki T., Naka M., Tanaka T., Hayashi H., Kobayashi R. Calcium-regulated modulator protein interacting agents inhibit smooth muscle calcium-stimulated protein kinase and ATPase. Mol Pharmacol. 1980 Jan;17(1):66–72. [PubMed] [Google Scholar]
  5. Ho W. K., Nakao K., Shibata S. The inhibitory action of two thrombin inhibitors (TI-189 and TI-233) on the contractile responses to 5-hydroxytryptamine and prostaglandin endoperoxide analogue (U-44069) in isolated vascular strips. Br J Pharmacol. 1980;71(2):399–405. doi: 10.1111/j.1476-5381.1980.tb10952.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Ito K., Karaki H., Urakawa N. The mode of contractile action of palytoxin on vascular smooth muscle. Eur J Pharmacol. 1977 Nov 1;46(1):9–14. doi: 10.1016/0014-2999(77)90137-6. [DOI] [PubMed] [Google Scholar]
  7. Karaki H., Murakami K., Nakagawa H., Ozaki H., Urakawa N. Effects of calmodulin antagonists on tension and cellular calcium content in depolarized vascular and intestinal smooth muscles. Br J Pharmacol. 1982 Dec;77(4):661–666. doi: 10.1111/j.1476-5381.1982.tb09344.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Karaki H., Suzuki T., Ozaki H., Urakawa N., Ishida Y. Dissociation of K+-induced tension and cellular Ca2+ retention in vascular and intestinal smooth muscle in normoxia and hypoxia. Pflugers Arch. 1982 Aug;394(2):118–123. doi: 10.1007/BF00582912. [DOI] [PubMed] [Google Scholar]
  9. Karaki H., Suzuki T., Urakawa N. Tris does not inhibit isolated vascular or intestinal smooth muscle contraction. Am J Physiol. 1981 Sep;241(3):H337–H341. doi: 10.1152/ajpheart.1981.241.3.H337. [DOI] [PubMed] [Google Scholar]
  10. Karaki H., Urakawa N. Possible role of endogenous catecholamines in the contractions induced in rabbit aorta by ouabain, sodium depletion and potassium depletion. Eur J Pharmacol. 1977 May 1;43(1):65–72. doi: 10.1016/0014-2999(77)90161-3. [DOI] [PubMed] [Google Scholar]
  11. Karaki H., Weiss G. B. Alterations in high and low affinity binding of 45Ca in rabbit aortic smooth muscle by norepinephrine and potassium after exposure to lanthanum and low temperature. J Pharmacol Exp Ther. 1979 Oct;211(1):86–92. [PubMed] [Google Scholar]
  12. Karaki H., Weiss G. B. Effects of stimulatory agents on mobilization of high and low affinity site 45Ca in rabbit aortic smooth muscle. J Pharmacol Exp Ther. 1980 Jun;213(3):450–455. [PubMed] [Google Scholar]
  13. Karaki H., Weiss G. B. Inhibitors of mitochondrial Ca++ uptake dissociate potassium-induced tension responses from increased 45Ca retention in rabbit aortic smooth muscle. Blood Vessels. 1981;18(1-2):28–35. doi: 10.1159/000158335. [DOI] [PubMed] [Google Scholar]
  14. Kerrick W. G., Hoar P. E., Cassidy P. S., Bolles L., Malencik D. A. Calcium-regulatory mechanisms. Functional classification using skinned fibers. J Gen Physiol. 1981 Feb;77(2):177–190. doi: 10.1085/jgp.77.2.177. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Namm D. H., Zucker J. L. Biochemical alterations caused by hypoxia in the isolated rabbit aorta. Correlation with changes in arterial contractility. Circ Res. 1973 Apr;32(4):464–470. doi: 10.1161/01.res.32.4.464. [DOI] [PubMed] [Google Scholar]
  16. Nasu T., Yui K., Nakagawa H., Ishida Y. Role of glycolysis in the tension development under anoxia in guinea pig taenia coli. Jpn J Pharmacol. 1982 Feb;32(1):65–71. doi: 10.1254/jjp.32.65. [DOI] [PubMed] [Google Scholar]
  17. Okamoto S., Hijikata A., Kinjo K., Kikumoto R., Okubo K. A novel series of synthetic thrombin-inhibitors having extremely potent and highly selective action. Kobe J Med Sci. 1975 Jun;21(2):43–51. [PubMed] [Google Scholar]
  18. PFAFFMAN M., URAKAWA N., HOLLAND W. C. ROLE OF METABOLISM IN K-INDUCED TENSION CHANGES IN GUINEA PIG TAENIA COLI. Am J Physiol. 1965 Jun;208:1203–1205. doi: 10.1152/ajplegacy.1965.208.6.1203. [DOI] [PubMed] [Google Scholar]
  19. Paul R. J., Peterson J. W. Relation between length, isometric force, and O2 consumption rate in vascular smooth muscle. Am J Physiol. 1975 Mar;228(3):915–922. doi: 10.1152/ajplegacy.1975.228.3.915. [DOI] [PubMed] [Google Scholar]
  20. Sparrow M. P., Mrwa U., Hofmann F., Rüegg J. C. Calmodulin is essential for smooth muscle contraction. FEBS Lett. 1981 Mar 23;125(2):141–145. doi: 10.1016/0014-5793(81)80704-1. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES